Enhertu 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26FT610
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,734
Award facts
- Contract value 100% obligated
- $18,734.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,734.10 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive award utilizing an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) valued at $999.9 million through December 2026, which serves as the parent contract vehicle enabling this delivery order.
This delivery order falls within AmerisourceBergen Drug Corp's comprehensive portfolio of pharmaceutical supply contracts supporting the Defense Health Agency and broader Department of Defense healthcare programs. Enhertu (trastuzumab deruxtecan) is a specialized oncology medication used in cancer treatment, reflecting the company's role in supplying specialty pharmaceuticals and brand-name medications to support military medical operations. As a child order under the larger DLA prime vendor contract, this award demonstrates the company's ongoing capability to fulfill federal medical supply requirements efficiently through established contract mechanisms designed to support military healthcare needs globally.
Quick answers
Who was awarded contract SPE2DR26FT610?
SPE2DR26FT610 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FT610 worth?
The government has obligated $18,734 on SPE2DR26FT610.
Is contract SPE2DR26FT610 an order under another contract?
Yes. SPE2DR26FT610 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT610 competed?
The extent of competition for SPE2DR26FT610 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award